Antimicrobial susceptibility of 136 Escherichia coli isolates from cases of neonatal meningitis and relationship with virulence

Clinical Microbiology and Infection

Volumn 13, Issue 12, 2007, Pages 1207-1210

  Houdouin, V ^a   Bonacorsi, S ^a   Bidet, P ^a   Bingen, Edouard ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Antimicrobial resistance; Escherichia coli; Neonatal meningitis; Phylogenetic group; Rat model; Virulence

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; NALIDIXIC ACID; PROTEIN PARC;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; WILD TYPE;

ESCHERICHIA COLI; RATTUS;

EID: 35848942830     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01838.x     Document Type: Article

References (20)

1. Stoll BJ, Gordon T, Korones SB et al. Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 72-80.
2. Saez-Llorens X, McCracken GH. Bacterial meningitis in children. Lancet 2003; 361: 2139-2148.
3. Schaad UB, Abdus Salam M, Aujard Y et al. Use of fluoroquinolones in pediatrics: Consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995; 14: 1-9.
4. Friedman S, Shah V, Ohlsson A, Matlow AG. Neonatal Escherichia coli infections: Concerns regarding resistance to current therapy. Acta Paediatr 2000; 89: 686-689.
5. Jones ME, Draghi DC, Karlowsky JA, Sahm DF, Bradley JS. Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by US hospital laboratories from 2000 to 2002. Ann Clin Microbiol Antimicrob 2004; 3: 3.
6. Johnson JR, Goullet P, Picard B, Moseley SL, Roberts PL, Stamm WE. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect Immun 1991; 59: 2311-2315.
7. Vila J, Simon K, Ruiz J et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186: 1039-1042.
8. Velasco M, Horcajada JP, Mensa J et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001; 33: 1682-1686.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-S15. Wayne, PA: CLSI, 2005.
10. Bonacorsi SP, Clermont O, Houduoin V et al. Molecular analysis and experimental virulence of French and North American Escherichia coli neonatal meningitis isolates; identification of new virulent clone. J Infect Dis 2003; 187: 1895-1906.
11. Vila J, Ruiz J, Goni P, De Anta MT. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996; 40: 491-493.
12. Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother 1998; 42: 2661-2667.
13. Houdouin V, Bonacorsi S, Brahimi N, Clermont O, Nassif X, Bingen E. A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis. Infect Immun 2002; 70: 5865-5869.
14. Horcajada JP, Soto S, Gajewski A et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43: 2962-2964.
15. Houdouin V, Bonacorsi S, Bidet P, Bingen-Bidois M, Barraud D, Bingen E. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 2006; 58: 748-751.
16. Moreno E, Prats G, Sabate M, Perez T, Johnson JR, Andreu A. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J Antimicrob Chemother 2006; 57: 204-211.
17. Duriez P, Clermont O, Bonacorsi S et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001; 147: 1671-1676.
18. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother 2006; 50: 649-653.
19. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005; 49: 4739-4744.
20. Martinez-Martinez L, Fernandez F, Perea EJ. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother 1999; 43: 277-279.